Edikan A. Ogunnaike
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Oncology 11
- CAR-T cell therapy research 9
- Peptidase Inhibition and Analysis 1
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Gianpietro Dotti (8 shared papers)Frances S. Ligler (5 shared papers)Sarah Ahn (4 shared papers)Zhen Nan Gu (4 shared papers)Guojun Chen (3 shared papers)Quanyin Hu (4 shared papers)Chao Wang (4 shared papers)Qian Chen (2 shared papers)
- Journals
- Advanced Materials (2 papers)Nature Biotechnology (1 paper)Journal of the American Chemical Society (1 paper)Biomaterials Science (1 paper)Journal of Materials Chemistry B (1 paper)
- Partner nations
- United StatesChinaRussia
In The Last Decade
Edikan A. Ogunnaike
13 papers receiving 872 citations
Edikan A. Ogunnaike's Hit Papers
Peers
Comparison fields: 5 of 65
- Oncology 380
- Immunology 284
- Biomedical Engineering 523
- Pharmaceutical Science 59
- Biomaterials 120
Countries citing papers authored by Edikan A. Ogunnaike
This map shows the geographic impact of Edikan A. Ogunnaike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edikan A. Ogunnaike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edikan A. Ogunnaike more than expected).
Fields of papers citing papers by Edikan A. Ogunnaike
This network shows the impact of papers produced by Edikan A. Ogunnaike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edikan A. Ogunnaike. The network helps show where Edikan A. Ogunnaike may publish in the future.
Co-authors
The 25 scholars most cited alongside Edikan A. Ogunnaike, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells Hit paper breakdown → | 2019 | 413 |
| 2 | 2022 | 162 | |
| 3 | 2021 | 119 | |
| 4 | 2021 | 74 | |
| 5 | 2023 | 30 | |
| 6 | 2019 | 28 | |
| 7 | 2020 | 21 | |
| 8 | 2021 | 9 | |
| 9 | 2025 | 7 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2025 | 2 |
About Edikan A. Ogunnaike
Edikan A. Ogunnaike is a scholar working on Oncology, Immunology, Biomedical Engineering, Molecular Biology and Biomaterials, having authored 13 papers that have together received 878 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (4 papers), Nanowire Synthesis and Applications (4 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Ubiquitin and proteasome pathways (1 paper), Peptidase Inhibition and Analysis (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Neuroscience and Neural Engineering (1 paper). The work is most often cited by research in Oncology (380 citations), Immunology (284 citations), Biomedical Engineering (523 citations), Pharmaceutical Science (59 citations) and Biomaterials (120 citations). Edikan A. Ogunnaike has collaborated with scholars based in United States, China and Russia. Frequent co-authors include Gianpietro Dotti, Frances S. Ligler, Sarah Ahn, Zhen Nan Gu, Guojun Chen, Quanyin Hu, Chao Wang, Qian Chen, Elena Dukhovlinova and Yevgeny Brudno. Their work appears in journals such as Advanced Materials, Nature Biotechnology, Journal of the American Chemical Society, Biomaterials Science and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.